News
Featured
Nursing Home Residents With Breast Cancer
Cell Phones and Cancer Risk
Dietary Habits and Colorectal Cancer Survival
MPE: Nedaplatin Associated With Less Toxicity
Let Us Answer Your Oncology Question
Chronic Lymphocytic Leukemia: A Nursing Perspective
Features
Integrative Medicine Practices That Can Help Pediatric Cancer Patients
A review of studies investigating the safety and efficacy of integrative and complementary medicine practices sought to determine their effects on children with cancer.
Nurses and Technology: How Much of What’s Online Is Off Limits?
How much of what's online is off limits? A review of ethics, principles, and guidelines for nurse and social worker behaviors regarding online searches.
Advisor Forum
Counseling Patients on Oral Chemotherapy
What are some tips for speaking to patients about adherence to oral cancer medications?
Adjusting Etoposide Dose When Used With Prezcobix
Do you have any resources that give specific guidelines or even anecdotal sources on how to adjust etoposide dose in a patient taking Prezcobix?
Assessment Tool for Immunotherapy Side Effects
My patient is receiving immunotherapy. What is the best tool for assessing side effects?
Fact Sheets
Cell Phones and Cancer Risk (Fact Sheet)
This fact sheet explores the technology of cell phones, radiofrequency energy and how it may affect the body, and the findings of research studies about cell phone exposure and cancer risk.
Acrylamide in Food and Cancer Risk (Fact Sheet)
This fact sheet explores the possible cancer risks caused by the chemical acrylamide in foodstuffs and consumer goods.
Trial Tracker
Challenges Faced by Oncology Nurses
Digital Issue
Editorial Board
Eucharia Borden, MSW, LCSW, OSW-C
Ann J. Brady, MSN, RN-BC, CHPN
Jiajoyce R. Conway, DNP, CRNP, AOCNP
Marianne Davies, DNP, ACNP, AOCNP
Frank dela Rama, RN, MS, AOCNS
Donald R. Fleming, MD
Leah A. Scaramuzzo, MSN, RN-BC, AOCN
Lisa A. Thompson, PharmD, BCOP
Rosemarie A. Tucci, RN, MSN, AOCN
Kara M.L. Yannotti, MMH, BSN, RN, CCRP
.
Sign Up for Free e-newsletters
ONA Articles
- Hodgkin Lymphoma Survivorship Marked by Periods of Actionable Distress
- Dose-Escalation Mitigates Risk of Grade 3/4 Adverse Events With Ruxolitinib for Myelofibrosis
- Stem Cell Transplantation Superior to Chemotherapy for Relapsed/Refractory DLBCL, Follicular Lymphoma
- Patients and Caregivers Worry About Cost of Cancer Care
- Integrative Medicine in Childhood Cancer: Practices That Can Help Pediatric Patients
- Navigating Prostate Cancer: A Patient's Experience From Diagnosis to Survivor
- Cell Phones and Cancer Risk (Fact Sheet)
- How Likely Are Oncologists to Refer for Palliative Care? Depends on Their Age
- Chemoimmunotherapy Increases Survival in Triple-Negative Breast Cancer
- Seeking an Explanation for the Lack of Research Focused in Pediatric Oncology Therapeutics
- Risk for Colon Cancer, Osteogenic Sarcoma Higher With Presence of Diamond-Blackfan Anemia
- G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
- Report From Childhood Cancer Survivor Study Identifies Long-Term Risks for VTE
- The Effect of Intravenous Hydration Strategy on Plasma Methotrexate Clearance During Intravenous High-dose Methotrexate Administration in Pediatric Oncology Patients
- Outcomes Worse for Minimally Invasive Hysterectomy vs Open Surgery
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |